Baxter ranks first in the 70 billion hemostatic market

beating Hyundai Pharmaceutical

FLOSEAL is expected to surpass 30 billion won in appearance this year

achosil, 19.2 billion won in 2019 → 16 billion won in 2021

GC Pharma's Greenplast Q Becomes 10 Billion Blockbuster

In the 70 billion won-shaped hemostatic market, Baxter Floseal is likely to surpass 30 billion won in sales this year, and is expected to rank first for the third consecutive year.

 

According to the drug distribution performance data, Baxter Flossal's sales reached 25.3 billion won and Hyundai Pharmaceutical's Tachosil's sales reached 12.5 billion won until the third quarter of this year, ranking first and second, respectively.

 

GC Pharma s Greenplast Q and Tisseel posted 8.8 billion won and 7.6 billion won in sales.

 

The Beri Plast P Combi Set in Germany remained in the bottom ranks with 1.8 billion won in performance.

 

Floseal's breakthrough has seen 23.2 billion won and 27.3 billion won (2021) from 2020, far exceeding Tachosil's sales of leading products, 17 billion won and 16 billion won.

 

Except for Floseal and Greenplast Q, all three products of Tachosil, Tisseel, and Beri Plast P Combi Set have a right-downward sales curve in the box.

 

Greenplast Q's performance in 2018, 2019, 2020, and 2021 was 9.8 billion, 10.9 billion, 11.5 billion, and 11.8 billion won.

 

During the same period, the appearance of the Tisseel and Beri Plast P Combi Set is 10.3 billion, 10.6 billion, 10 billion, 10.1 billion, and 2 billion, 4.3 billion, 3 billion, and 2.4 billion, respectively.

 

Floseal, which obtained approval from the Ministry of Food and Drug Safety in 2008, is a syringe kit-type product that is rarely listed as non-payment among major hemostatic products with 500 IU/mL of human thrombin and 704mg of purified gelatin.

 

Tachosil is a white sponge-type hemostatic agent at room temperature below 25 °C.

 

The health insurance drug price is listed as 71,752 won for 3cm*2.5cm, 374,597 won for 9.5cm*4.8cm, 193,697 won for 4.8cm*4.8cm, 211,642 won for 4.8cm*4.8cm.

 

Greenplast Q in the form of PF syringe is a hemostatic agent mainly composed of 500 IU/mL of thrombin, 1000 kIU/mL of afrotin, and 95 mg/mL of fibrinogen.

 

Like Tisseel - 20 °C is a biological product of frozen storage and distribution.

 

The drug price is 85,028 won for 2mL and 167,314 won for 4mL.

 

Tisseel, which was approved in 2004, has a pre-field syringe with 3 000kIU of Aporotinin, 5.88mg of calcium chloride hydrate, 500U/mL of human Thrombin, and 91mg of Fibrinogen, and the registration consists of 2mL, 119,508 won, 4mL, 191,268 won, 10mL, and 506,27 won.

 

Beri Plast P Combi Se is a similar composition to Tisseel, and the packaging unit is in the form of freeze-dried vial + liquid vial, forming an insurance drug price of 95,590 won for 1mL and 191,234 won for 2mL